BRK-B vs CANG
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
Cango Inc. exhibits severe financial distress, anchored by a critical Piotroski F-Score of 1/9, indicating fundamental weakness across nearly all health metrics. While the company shows impressive top-line revenue growth (87.9% YoY), this is completely offset by catastrophic profit margins (-90.39%) and a devastating ROE of -95.23%. Liquidity is a primary concern with a Quick Ratio of 0.25, suggesting an inability to meet short-term obligations. The stock is currently a classic 'value trap,' trading at a low Price/Book (0.38) but lacking the operational stability to justify a recovery.
Compare Another Pair
Related Comparisons
BRK-B vs CANG: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Cango Inc. (CANG) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.